Related Experiment Videos
Fat embolism in infancy after intravenous fat infusions
Archives of Disease in Childhood
|March 1, 1978
Summary
Infants receiving prolonged Intralipid 20% infusions can develop fat embolism, a condition termed fat overloading syndrome. High infusion rates may contribute to this rare but serious complication in infants.
Area of Science:
- Pediatrics
- Neonatology
- Clinical Pathology
Background:
- Intravenous fat emulsions, such as Intralipid 20%, are crucial for nutritional support in infants.
- Fat embolism is a known complication, typically associated with trauma, but its occurrence in infants receiving Intralipid requires specific investigation.
Observation:
- Four infant cases of fat embolism were identified during prolonged Intralipid 20% infusions.
- Clinical presentation resembled post-traumatic fat embolism, prompting the term 'fat overloading syndrome'.
- Histopathological evidence confirmed fat embolism in all recorded infant cases.
Findings:
- Prolonged intravenous fat infusion, specifically Intralipid 20%, is linked to fat embolism in infants.
- Transiently high infusion rates of Intralipid appear to be a significant etiological factor.
- This study provides the first histopathological proof of fat embolism in infants due to Intralipid therapy.
Implications:
- Clinicians should be aware of fat overloading syndrome as a potential complication in infants receiving Intralipid.
- Careful monitoring and potentially adjusted infusion rates are recommended to mitigate the risk of fat embolism.
- Further research is warranted to fully elucidate the pathophysiology and optimize the safe use of Intralipid in pediatric populations.